Biotech drug maker Amgen plans to launch six biosimilar drugs starting in 2017, according to published reports.

Surprise inspections at 40 compounding pharmacies in Massachusetts last fall have led to 10 being ordered to stop sterile compounding, according to published reports.

Israeli drug maker Taro Pharmaceutical Industries and Indian drug maker Sun Pharmaceutical Industries have terminated their merger agreement, the companies said in a joint statement Friday.

Pharmacy automation system manufacturer Innovation has appointed Stephen Donohue as divisional VP sales, chain and high volume, the company said.

Reporting on the third quarter ended Dec. 31, Prestige Brands' CEO Matthew Mannelly told analysts he is "cautiously optimistic" regarding cough-cold reorders given the high consumption levels at retail in late December through January.

Verizon Communications on Thursday elected Greg Wasson, Walgreens president and CEO, to the Verizon board of directors, effective March 1.

Republican and Democratic senators have re-introduced legislation that would ban patent settlements between branded and generic drug companies that critics allege violate antitrust laws, according to published reports.

Despite nearly half of shoppers using social media every day, less than one-fifth shop through them, according to a new study by PwC.

Ahold has appointed the former head of one of its European supermarket chains to an executive position in its U.S. division.

A new report sheds light on some of the opportunities and challenges that exist in follow-on biologics, arguing that their opportunity to generate value depends on factors like the speed of development, clarity of regulation, ease of access and the roles of all stakeholders.

WebMD Health launched the WebMD Allergy app for the iPhone, a mobile resource that empowers consumers to take control of their allergies.

Walgreens promoted Joseph Magnacca to EVP from SVP. Magnacca also retains his title as president of daily living products and solutions. In this capacity, Magnacca will continue to oversee Walgreens merchandising and inventory strategy, private brands, insights and analytics, and the New York-based Duane Reade drug store chain, which Walgreens acquired in 2010.

And that means Magnacca will continue to do what he does best, which is change everything you've ever thought you knew about drug store retailing across the front-end. If you've ever met him in person, you'd know he's not a static person. He doesn't stand still. He's always moving toward identifying that next thing, that next offering or presentation that resonates with people at the crossroads of health and happy and at the same time is something they never thought they'd find in a drug store.